Keyphrases
Acute Lesions
29%
Aminosteroid
14%
Behavioral Recovery
14%
Cincinnati
11%
Drug Levels
11%
DuPont
14%
Duration of Therapy
14%
Excitatory Amino Acid Transporter
11%
Georgetown University
14%
High Risk
14%
Histologic
11%
Human Spinal Cord Injury
11%
Injury Levels
14%
Injury Outcomes
11%
Lesion Volume
29%
Medical University
11%
Mesylate
14%
Methylprednisolone
44%
Nalmefene
14%
Neurological Recovery
14%
Neuroprotective Agents
11%
Ohio State University
14%
Opioid Receptors
14%
Preclinical Data
29%
Preclinical Investigation
11%
Preclinical Trials
14%
Promising Treatment
14%
Rational Design
11%
Receptor Blockers
25%
San Francisco
14%
Spinal Cord Compression
25%
Spinal Cord Injury
100%
Spinal Cord Injury Model
11%
Spinal Cord Injury Treatment
11%
Therapeutic Window
14%
Thyrotropin
14%
Tirilazad
14%
Traumatic Brain Injury
11%
Treatment Protocol
40%
University of California
14%
University of South Carolina
11%
University of Washington
14%
Yale University
14%
Pharmacology, Toxicology and Pharmaceutical Science
Amino Acid Receptor Blocking Agent
6%
Cerebrovascular Accident
13%
Clinical Trial
13%
Excitatory Amino Acid
6%
Glucocorticoid
13%
Isoprenaline
13%
Methylprednisolone
26%
Nalmefene
13%
Narcotic Antagonist
13%
Neuroprotective Agent
6%
Protirelin Derivative
6%
Spinal Animal
40%
Spinal Cord Injury
100%
Therapeutic Window
13%
Thyrotropin
6%
Tirilazad
13%
Traumatic Brain Injury
6%
Neuroscience
Blood Plasma
6%
Cerebrovascular Accident
6%
Excitatory Amino Acid Receptor
6%
Glucocorticoid
6%
Isoprenaline
6%
Methylprednisolone
26%
Nalmefene
6%
Narcotic Antagonist
6%
Neuroprotective Agent
6%
Neurotrauma
6%
Protirelin Derivative
6%
Spinal Cord Injury
66%
Traumatic Brain Injury
6%